CHELMSFORD, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Brooks Automation, Inc. (Nasdaq:BRKS), announced today that it has acquired certain assets from RURO, Inc., based in Frederick, MD. These assets include the FreezerPro® web-based software which enables access to information on stored samples from any location on any device. As part of the acquisition, Brooks also entered an exclusive license agreement to sell and distribute RURO’s BioBankPro® software which integrates the functionality of FreezerPro with other data sources, often from external sources or instruments used in the workflow of sample-based research.
“The RURO software platform enhances our growing portfolio of informatics solutions, providing customers with complete insight into their samples and enabling them to accelerate their research,” said Dusty Tenney, president of Brooks Life Sciences. “These biorepository software tools are a natural fit into our life sciences portfolio as informatics integrates our services, consumables and infrastructure products by capturing comprehensive sample management information for customers globally. We are taking another step to enhance our customer’s sample workflow which enables healthier and brighter tomorrows for patients.”
“Our laboratory freezer sample management software is a perfect complement to Brooks Life Sciences,” said Vlad Lebedev, CEO RURO, Inc., “integrating their comprehensive sample management solutions with intuitive, reliable and secure software tools at customers across multiple end markets.”
The acquisition is the latest addition to the growing portfolio of Brooks Life Sciences’ products, services, and informatics. FreezerPro and BioBankPro expand Brooks’ software offerings into a full range of informatics solutions that will now address any size laboratory, biobank or enterprise managing biological samples.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences. Brooks’ technologies, engineering competencies and global service capabilities provide customers speed to market and ensure high uptime and rapid response, which equate to superior value in their mission-critical controlled environments. Since 1978, Brooks has been a leading partner to the global semiconductor manufacturing market. Since 2011, Brooks has applied its automation and cryogenics expertise to meet the sample storage needs of customers in the life sciences industry. Brooks’ life sciences offerings include a broad range of products and services for on-site infrastructure for sample management in temperatures of ‑20°C to -150°C, as well as comprehensive outsource service solutions across the complete life cycle of biological samples including collection, transportation, processing, storage, protection, retrieval and disposal. Brooks is headquartered in Chelmsford, MA, with direct operations in North America, Europe and Asia. For more information, visit www.brooks.com.
About RURO, Inc.
RURO, Inc. was founded in 2006 and is headquartered in the heart of Maryland’s biotechnology corridor. RURO develops state of the art computer software for research, biotechnological, pharmaceutical, healthcare and government (homeland security) laboratories in the US and worldwide. RURO is a web applications leader, combining world-class innovation and industry experience so individuals can use computer software in new ways and places. Their recent line of biological applications is designed to increase the productivity of scientific, biotech and pharmaceutical laboratories while maintaining the highest level of security, versatility and knowledge.
“Safe Harbor Statement” under Section 21E of the Securities Exchange Act of 1934
Some statements in this release are forward-looking statements made under Section 21E of the Securities Exchange Act of 1934. These statements are neither promises nor guarantees but involve risks and uncertainties, both known and unknown, that could cause Brooks' financial and business results to differ materially from our expectations. They are based on the facts known to management at the time they are made. These forward-looking statements include, but are not limited to, statements about the anticipated benefits of the acquisition of the RURO assets. Factors that could cause results to differ from our expectations include the following: potential difficulties with the integration of the assets into Brooks Life Science Systems and potential adverse reactions or changes to business relationships resulting from Brooks’ ownership of the acquired assets. In addition, actual results are subject to other risks that relate more broadly to Brooks’ overall business, including those that we have described in our filings with the Securities and Exchange Commission, including but not limited to our Annual Report on Form 10-K, current reports on Form 8-K and our quarterly reports on Form 10-Q. As a result we can provide no assurance that our future results will not be materially different from those projected. Brooks expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statement to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based. Brooks undertakes no obligation to update the information contained in this press release.
Senior Managing Director
News Provided by GlobeNewswire
© 2017 GlobeNewswire, Inc. All Rights Reserved